Last reviewed · How we verify
fiblast,gelatin sponge,fibrin glue — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
fiblast,gelatin sponge,fibrin glue (fiblast,gelatin sponge,fibrin glue) — Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| fiblast,gelatin sponge,fibrin glue TARGET | fiblast,gelatin sponge,fibrin glue | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- fiblast,gelatin sponge,fibrin glue CI watch — RSS
- fiblast,gelatin sponge,fibrin glue CI watch — Atom
- fiblast,gelatin sponge,fibrin glue CI watch — JSON
- fiblast,gelatin sponge,fibrin glue alone — RSS
Cite this brief
Drug Landscape (2026). fiblast,gelatin sponge,fibrin glue — Competitive Intelligence Brief. https://druglandscape.com/ci/fiblast-gelatin-sponge-fibrin-glue. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab